Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
December 9, 2019Blood AdvancesOpen Access

Invasive fungal infections in acute myeloid leukemia treated with venetoclax and hypomethylating agents

View Full Paper
Ask AI
Bookmark
Share

Authors

IAIbrahim AldossCity of HopeSDSanjeet DadwalCity Of Hope National Medical CenterJZJianying ZhangInner Mongolia Agricultural University

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Aldoss et al. (2019) studied this question.

synapsesocial.com/papers/6a7d2469ec6dad7f5aaa0b9fhttps://doi.org/10.1182/bloodadvances.2019000930
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Antimicrobial Prophylaxis for Adult Patients With Cancer-Related Immunosuppression: ASCO and IDSA Clinical Practice Guideline Update2018 · 603 citations
  2. 2Association of leukemia genetics with response to venetoclax and hypomethylating agents in relapsed/refractory acute myeloid leukemia2019 · 101 citations
  3. 3Antifungal Prophylaxis in Cancer Patients After Chemotherapy or Hematopoietic Stem-Cell Transplantation: Systematic Review and Meta-Analysis2007 · 298 citations
  4. 4Towards a targeted, risk‐based, antifungal strategy in neutropenic patients2000 · 182 citations
  5. 5Venetoclax combined with decitabine or azacitidine in treatment-naive, elderly patients with acute myeloid leukemia2018 · 1,893 citations